A new monopolar RF system gains rapid traction in North America, challenging Morpheus8's market dominance in the RF microneedling space.
Cynosure Lutronic's XERF monopolar RF platform is gaining rapid adoption across North American medspa and surgical practices, emerging as a credible alternative to InMode's Morpheus8 in the RF microneedling category. Monopolar RF delivers energy deeper into the dermis and subcutis than fractional microneedling RF, making it suitable for skin tightening, collagen remodeling, and larger-area treatments.
The XERF's market traction reflects both competitive pricing and clinical efficacy. Morpheus8 has dominated the fractional RF-microneedling segment since its launch, but monopolar RF offers a different clinical profile—broader energy distribution, fewer passes required, and potentially faster treatment times. Practices seeking to diversify their RF portfolio or reduce per-treatment cost-of-goods may view XERF as a complementary or alternative investment.
XERF's rapid adoption signals that monopolar RF is fragmenting the RF market and challenging Morpheus8's dominance.
For device-dependent practices, this underscores the importance of evaluating energy-modality portfolios holistically. RF microneedling, monopolar RF, and laser systems each serve distinct clinical niches and patient populations; competitive pressure is driving innovation and pricing discipline across all three.
Source: original report ↗
Frequently asked questions
What is the difference between monopolar RF and fractional RF microneedling?
Monopolar RF delivers energy deeper into the dermis and subcutis with broader energy distribution, requiring fewer passes and potentially faster treatment times. Fractional RF microneedling, like Morpheus8, targets smaller treatment zones with more precision, making each modality suited to different clinical applications and patient populations.
Is Cynosure Lutronic's XERF cheaper than Morpheus8?
XERF is gaining adoption partly due to competitive pricing relative to Morpheus8, though exact pricing varies by distributor and region. Practices are evaluating XERF as a way to reduce per-treatment cost-of-goods while maintaining clinical efficacy.
Should I buy XERF or Morpheus8 for my medspa?
Both serve different clinical niches—Morpheus8 excels at fractional, targeted treatments while XERF is better for skin tightening, collagen remodeling, and larger-area treatments. Many practices benefit from owning both to diversify their RF portfolio and serve a wider range of patient needs.
What is monopolar RF best used for?
Monopolar RF is ideal for skin tightening, collagen remodeling, and treating larger body areas due to its deeper energy penetration and broader distribution. It requires fewer treatment passes than fractional RF, making it efficient for patients seeking non-invasive body and face contouring.
Is XERF taking market share from Morpheus8?
XERF is gaining rapid traction in North America as a credible alternative, reflecting competitive pricing and clinical efficacy that appeal to practices diversifying their RF offerings. However, Morpheus8 remains dominant in the fractional RF-microneedling segment; the two systems target somewhat different clinical applications rather than directly replacing each other.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
